Markets:

Overview

News

Currencies

International

Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

78.70 -1.73 (-2.15%)

Streaming Delayed Price Updated: 12:23 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Drug Maker Organon Stock Scores Relative Strength Upgrade ↗

February 28, 2024

In a welcome move, drug maker Organon stock saw its Relative Strength Rating rise from 66 to 71 on Wednesday.

Via Investor's Business Daily

ANI Pharmaceuticals's Earnings Outlook ↗

February 28, 2024

Via Benzinga

Truist Securities Maintains Buy Rating for ANI Pharmaceuticals: Here's What You Need To Know ↗

February 16, 2024

Via Benzinga

Why Is Generic Drug Player ANI Pharmaceuticals Stock Trading Lower Today? ↗

November 08, 2023

ANI Pharmaceuticals Inc's (NASDAQ: ANIP) third-quarter revenues were $131.8 million, up 57.3% Y/Y, beating the

Via Benzinga

Expert Ratings for ANI Pharmaceuticals ↗

October 19, 2023

Via Benzinga

Analyst Expectations for ANI Pharmaceuticals's Future ↗

September 13, 2023

Via Benzinga

ANI Pharmaceuticals Inc. (NASDAQ: ANIP) Records 52-Week High Wednesday Morning

August 23, 2023

Via Investor Brand Network

What 4 Analyst Ratings Have To Say About ANI Pharmaceuticals ↗

August 21, 2023

Via Benzinga

Where ANI Pharmaceuticals Stands With Analysts ↗

July 21, 2023

Via Benzinga

Looking Into ANI Pharmaceuticals's Return On Capital Employed ↗

May 23, 2023

Via Benzinga

7 A-Rated Biotech Stocks for Your August Buy List ↗

August 17, 2023

Investing in biotech stocks means accepting a long R&D window, but the rewards when your A-rated biotech stocks come through are huge.

Via InvestorPlace

ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference

May 22, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 16, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity

May 15, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

Why ANI Pharmaceuticals Stock Is Soaring Today ↗

May 08, 2023

ANI Pharmaceuticals Inc's (NASDAQ: ANIP) Q1 revenues were $106.8 million, +65.6% Y/Y, beating the

Via Benzinga

Earnings Preview For ANI Pharmaceuticals ↗

May 05, 2023

Via Benzinga

ANI Pharmaceuticals Earnings Perspective: Return On Capital Employed ↗

March 13, 2023

Via Benzinga

ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock

May 12, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock

May 11, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

Stocks Reverse Gains Ahead Of Slew Of Inflation Data ↗

May 08, 2023

Stocks are lower this afternoon, as investors await a deluge of inflation data amid a rally for the banking sector.

Via Talk Markets

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 08, 2023

Via Benzinga

Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 08, 2023

Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China.

Via Benzinga

ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

May 08, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ET

April 27, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ

April 26, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP

April 24, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the FDA Approval of Colestipol Hydrochloride Tablets USP

April 04, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance

March 09, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

Guggenheim Creates Bullish Pitch For ANI Pharma On Progress With Cortrophin Launch ↗

March 01, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 ↗

March 01, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.